BCL2 and cancer: The mRNA expression level of Bcl-2 was up-regulated in cisplatin-resistant cancer cells, but its P-value, which was < 0.05, was only significant in the differential expression of A2780DDP and A2780 cells (Supplementary Figure 6A).